Generation and modelling of megavoltage photon beams for contrast-enhanced radiation therapy.
Contrast-enhanced radiation therapy (CERT) is a treatment approach involving the irradiation of tumours containing high atomic number (Z) contrast media, using low-quality x-ray beams. This work describes the experimental generation of x-ray beams using a linear accelerator with low-Z target materials (beryllium and aluminium), in order to produce photon energy spectra appropriate for CERT. Measurements were made to compare the experimental beams to conventional linear accelerator photon beams in terms of per cent depth dose. Monte Carlo simulation was used to model the generation of each beam, and models were validated against experimental measurement. Validated models were used to demonstrate changes in photon spectra as well as to quantify the variation of tumour dose enhancement with iodinated contrast medium concentration in a simulated tumour volume. Finally, the ratio of the linear attenuation coefficient for iodinated contrast medium relative to water was determined experimentally as a function of iodine concentration. Beams created with low-Z targets show significant changes in energy spectra compared to conventional beams. For the 4 MeV/Be beam, for example, 33% of photons have energies below 60 keV. Measurements and calculation show that both the linear attenuation coefficient ratio and dose enhancement factor (DEF) increase most rapidly at concentrations below 46 mg I ml(-1). There is a significant dependence of DEF on electron energy and a lesser dependence on target material. The 4 MeV/Be beam is the most promising in terms of magnitude of DEF - for example, DEF values of 1.16 and 1.29 are obtained for concentrations of 20 mg I ml(-1) and 50 mg I ml(-1), respectively. DEF will increase or decrease, respectively, for shallower or deeper tumours at a rate of approximately 1.1% cm(-1). In summary, we show that significant dose enhancement is possible by altering the linear accelerator target and filtration, but the magnitude is highly dependent on contrast medium concentration.
Robar
J L
JL
Department of Radiation Oncology, Dalhousie University, 5820 University Street, Halifax, Nova Scotia B3H 1V7, Canada. james.robar@cdha.nshealth.ca
D000535:Aluminum / Q000737:chemistry; D001608:Beryllium / Q000737:chemistry; D003287:Contrast Media / Q000494:pharmacology*; D004583:Electrons; D006801:Humans; D007455:Iodine / Q000737:chemistry; D009010:Monte Carlo Method; D009369:Neoplasms / Q000378:metabolism / Q000532:radiotherapy*; D010315:Particle Accelerators; D019047:Phantoms, Imaging; D017785:Photons; D011874:Radiometry; D011878:Radiotherapy / Q000379:methods*; D011879:Radiotherapy Dosage; D014965:X-Rays
D003287:Contrast Media; D007455:Iodine; D000535:Aluminum; D001608:Beryllium